Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort
DOI:
https://doi.org/10.2340/actadv.v103.5269Keywords:
psoriasis, psoriatic arthritis, screeningAbstract
Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to joint damage. While screening questionnaires have been developed, their performance varies. The objective of this study was to develop a referral tool for dermatologists to identify psoriasis patients with concomitant psoriatic arthritis for rheumatological referral. This study used data from the DAPPER study, in which psoriasis patients were screened by a rheumatologist for the presence of concomitant psoriatic arthritis. Multivariable regression analysis was used to identify predictive variables for the presence of concomitant psoriatic arthritis: treatment history with conventional systemic drugs (odds ratio (OR) 2.97, 95% confidence interval (95% CI) 1.01–8.74, p = 0.04), treatment history with biologicals/small molecule inhibitors (OR 2.90, 95% CI 1.52–5.53, p = 0.01), patient-reported history of joint pain not caused by trauma (OR 4.23, 95% CI 1.21–14.79, p = 0.01), patient-reported history of swollen joints (OR 4.25, 95% CI 2.17–8.32, p < 0.001), and patient-reported history of sausage-like swollen digits (OR 2.38, 95% CI 1.25–4.55, p = 0.01). Based on these variables, a referral tool was created with an area under the curve of 0.82. This referral tool could be used to aid dermatologists to identify psoriasis patients with concomitant psoriatic arthritis, who may benefit from rheumatological referral.
Downloads
References
Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003; 42: 1460-1468.
https://doi.org/10.1093/rheumatology/keg384 DOI: https://doi.org/10.1093/rheumatology/keg384
Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015; 74: 1045-1050.
https://doi.org/10.1136/annrheumdis-2013-204858 DOI: https://doi.org/10.1136/annrheumdis-2013-204858
Tillett W, Charlton R, Nightingale A, Snowball J, Green A, Smith C, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford) 2017; 56: 2109-2113.
https://doi.org/10.1093/rheumatology/kex323 DOI: https://doi.org/10.1093/rheumatology/kex323
Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O'Dwyer JL, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet 2015; 386: 2489-2498.
https://doi.org/10.1016/S0140-6736(15)00347-5 DOI: https://doi.org/10.1016/S0140-6736(15)00347-5
Coates LC, Orbai AM, Morita A, Benichou O, Kerr L, Adams DH, et al. Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients' health-related quality of life and productivity. BMC Rheumatol 2018; 2: 24.
https://doi.org/10.1186/s41927-018-0030-y DOI: https://doi.org/10.1186/s41927-018-0030-y
Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 2015; 73: 242-248.
https://doi.org/10.1016/j.jaad.2015.05.001 DOI: https://doi.org/10.1016/j.jaad.2015.05.001
Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol 2009; 27: 469-474.
Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007; 57: 581-587.
https://doi.org/10.1016/j.jaad.2007.04.001 DOI: https://doi.org/10.1016/j.jaad.2007.04.001
Tinazzi I, Adami S, Zanolin EM, Caimmi C, Confente S, Girolomoni G, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford) 2012; 51: 2058-2063.
https://doi.org/10.1093/rheumatology/kes187 DOI: https://doi.org/10.1093/rheumatology/kes187
Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis 2009; 68: 497-501.
https://doi.org/10.1136/ard.2008.089441 DOI: https://doi.org/10.1136/ard.2008.089441
Audureau E, Roux F, Lons DD, Bagot M, Cantagrel A, Dernis E, et al. Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'. J Eur Acad Dermatol Venereol 2018; 32: 1950-1953.
https://doi.org/10.1111/jdv.14861 DOI: https://doi.org/10.1111/jdv.14861
Coates LC, Walsh J, Haroon M, FitzGerald O, Aslam T, Al BF, et al. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken) 2014; 66: 1410-1416.
https://doi.org/10.1002/acr.22284 DOI: https://doi.org/10.1002/acr.22284
Harle P, Letschert K, Wittig B, Mrowietz U. Sensitivity of the GEPARD patient questionnaire to identify psoriatic arthritis in patients with psoriasis in daily practice: the GEPARD-Life Study. Dermatology 2016; 232: 597-605.
https://doi.org/10.1159/000448029 DOI: https://doi.org/10.1159/000448029
Khraishi M, Mong J, Mugford G, Landells I. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): a sensitive and specific tool to diagnose psoriatic arthritis patients. J Cutan Med Surg 2011; 15: 143-149.
https://doi.org/10.2310/7750.2011.10018 DOI: https://doi.org/10.2310/7750.2011.10018
Salaffi F, Di Carlo M, Bugatti L, Lato V, Nicolini M, Carotti M. Development and pilot-testing of a new tool to screen psoriasis patients for the presence of psoriatic arthritis: the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire. J Eur Acad Dermatol Venereol 2017; 31: e167-e169.
https://doi.org/10.1111/jdv.13902 DOI: https://doi.org/10.1111/jdv.13902
Urruticoechea-Arana A, Benavent D, Leon F, Almodovar R, Belinchon I, de la Cueva P, et al. Psoriatic arthritis screening: a systematic literature review and experts' recommendations. PLoS One 2021; 16: e0248571.
https://doi.org/10.1371/journal.pone.0248571 DOI: https://doi.org/10.1371/journal.pone.0248571
Van Hal TW, Mulder MLM, Wenink MH, Pasch MC, Van den Hoogen FHJ, Van den Reek J, et al. Discovery of psoriatic arthritis in psoriasis patients for early rheumatological referral (DAPPER) study: a prospective observational cohort. Acta Derm Venereol 2022; 102: 2225.
https://doi.org/10.2340/actadv.v102.2225 DOI: https://doi.org/10.2340/actadv.v102.2225
van Hal TW, Van den Reek JM, Groenewoud HM, Pasch MC, Van den Hoogen FH, Wenink MH, et al. Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): protocol for a longitudinal observational study. JMIR Res Protoc 2021; 10: e31647.
https://doi.org/10.2196/31647 DOI: https://doi.org/10.2196/31647
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015; 162: 55-63.
https://doi.org/10.7326/M14-0697 DOI: https://doi.org/10.7326/M14-0697
Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
https://doi.org/10.1159/000250839 DOI: https://doi.org/10.1159/000250839
Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212.
https://doi.org/10.1067/S0190-9622(03)00910-1 DOI: https://doi.org/10.1067/S0190-9622(03)00910-1
Klaassen KM, van de Kerkhof PC, Bastiaens MT, Plusje LG, Baran RL, Pasch MC. Scoring nail psoriasis. J Am Acad Dermatol 2014; 70: 1061-1066.
https://doi.org/10.1016/j.jaad.2014.02.010 DOI: https://doi.org/10.1016/j.jaad.2014.02.010
Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013; 69: 729-735.
https://doi.org/10.1016/j.jaad.2013.07.023 DOI: https://doi.org/10.1016/j.jaad.2013.07.023
Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol 2019; 71: 5-32.
https://doi.org/10.1002/art.40726 DOI: https://doi.org/10.1002/art.40726
Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C. Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 2018; 48: 263-273.
https://doi.org/10.1016/j.semarthrit.2018.02.002 DOI: https://doi.org/10.1016/j.semarthrit.2018.02.002
Garg N, Truong B, Ku JH, Devere TS, Ehst BD, Blauvelt A, et al. A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic. Clin Rheumatol 2015; 34: 1745-1751.
https://doi.org/10.1007/s10067-014-2658-3 DOI: https://doi.org/10.1007/s10067-014-2658-3
Gisondi P, Bellinato F, Targher G, Idolazzi L, Girolomoni G. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis. Ann Rheum Dis 2022; 81: 68-73.
https://doi.org/10.1136/annrheumdis-2021-219961 DOI: https://doi.org/10.1136/annrheumdis-2021-219961
van Muijen ME, van Hal TW, Groenewoud HMM, van den Reek J, de Jong E. The skin may clear but the arthritis won't disappear: focusing on concomitant and new-onset psoriatic arthritis in a daily practice cohort of psoriasis patients on biologic therapy. Psoriasis (Auckl) 2020; 10: 29-37.
https://doi.org/10.2147/PTT.S270619 DOI: https://doi.org/10.2147/PTT.S270619
Ogdie A, Shin DB, Love TJ, Gelfand JM. Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study. Rheumatology (Oxford) 2022; 61: 1877-1884.
https://doi.org/10.1093/rheumatology/keab622 DOI: https://doi.org/10.1093/rheumatology/keab622
Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheumatol 2017; 69: 622-629.
https://doi.org/10.1002/art.39973 DOI: https://doi.org/10.1002/art.39973
Meer E, Merola JF, Fitzsimmons R, Love TJ, Wang S, Shin D, et al. Does biologic therapy impact the development of PsA among patients with psoriasis? Ann Rheum Dis 2022; 81: 80-86.
https://doi.org/10.1136/annrheumdis-2021-220761 DOI: https://doi.org/10.1136/annrheumdis-2021-220761
Cui R, Chen M, Li X, Wang Q, Tong Q, Zhang H, et al. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: a multicenter study. J Dermatol 2022; 49: 615-623.
https://doi.org/10.1111/1346-8138.16355 DOI: https://doi.org/10.1111/1346-8138.16355
FitzGerald O, Pennington SR. HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis. Nat Rev Rheumatol 2022; 18: 123-124.
https://doi.org/10.1038/s41584-022-00748-w DOI: https://doi.org/10.1038/s41584-022-00748-w
Mulder MLM, van Hal TW, Wenink MH, Koenen H, van den Hoogen FHJ, de Jong E, et al. Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review. Arthritis Res Ther 2021; 23: 168.
https://doi.org/10.1186/s13075-021-02545-4 DOI: https://doi.org/10.1186/s13075-021-02545-4
Iragorri N, Hazlewood G, Manns B, Bojke L, Spackman E, Early detection to improve outcome in people with undiagnosed psoriatic arthritis study G. model to determine the cost-effectiveness of screening psoriasis patients for psoriatic arthritis. Arthritis Care Res (Hoboken) 2021; 73: 266-274.
https://doi.org/10.1002/acr.24110 DOI: https://doi.org/10.1002/acr.24110
Sieper J, van der Heijde D, Landewe R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 2009; 68: 784-788.
https://doi.org/10.1136/ard.2008.101501 DOI: https://doi.org/10.1136/ard.2008.101501
Maksymowych WP, Mallon C, Morrow S, Shojania K, Olszynski WP, Wong RL, et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009; 68: 948-953.
https://doi.org/10.1136/ard.2007.084244 DOI: https://doi.org/10.1136/ard.2007.084244
Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008; 59: 686-691.
https://doi.org/10.1002/art.23568 DOI: https://doi.org/10.1002/art.23568
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Tamara W. van Hal, Michelle L.M. Mulder, Mark H. Wenink, Frank H.J. van den Hoogen, Jake S.F. Maurits, Marcel C. Pasch, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
